Onsdag 28 Oktober | 18:13:11 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Arise - Leaves an eventful 2023 for a potentially prosperous 2024

2024-02-16 08:00:00

Redeye updates its estimates and fair value range following Arise’s Q4 2023 report. The report, which was softer than expected due to higher-than-expected costs, managed to generate 58% EBITDA growth, and the board proposes a 20% dividend increase. The project portfolio looks greater than ever, and Arise targets one project sale in 2024. Furthermore, production capacity is set to increase by nearly 30% pa as 33MW project Lebo goes live in Q1 2024. With nearly SEK1bn in cash on hand, we would not be too surprised to see Arise performing some M&A during the year.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/